138
Participants
Start Date
August 1, 2016
Primary Completion Date
September 24, 2017
Study Completion Date
October 19, 2017
Placebo
Intravenous infusion of matching placebo for either SAGE-547 60 μg/kg/h or 90 μg/kg/h.
SAGE-547 60 μg/kg/h
Intravenous infusion of SAGE-547.
SAGE-547 90 μg/kg/h
Intravenous infusion of SAGE-547.
Sage Investigational Site, Glen Oaks
Sage Investigational Site, Philadelphia
Sage Investigational Site, Chapel Hill
Sage Investigational Site, Raleigh
Sage Investigational Site, Charlotte
Sage Investigational Site, Atlanta
Sage Investigational Site, Pensacola
Sage Investigational Site, Gainesville
Sage Investigational Site, Orlando
Sage Investigational Site, Miramar
Sage Investigational Site, Miami
Sage Investigational Site, Pinellas Park
Sage Investigational Site, Flowood
Sage Investigational Site, Edgewood
Sage Investigational Site, Owensboro
Sage Investigational Site, Columbus
Sage Investigational Site, Dayton
Sage Investigational Site, Hoffman Estates
Sage Investigational Site, Wichita
Sage Investigational Site, Rogers
Sage Investigational Site, Richardson
Sage Investigational Site, Houston
Sage Investigational Site, Houston
Sage Investigational Site, San Antonio
Sage Investigational Site, Orem
Sage Investigational Site, Chandler
Sage Investigational Site, Lemon Grove
Sage Investigational Site, Orange
Sage Investigational Site, Ventura
Sage Investigational Site, Boston
Sage Investigational Site, Boston
Sage Investigational Site, Marlton
Supernus Pharmaceuticals, Inc.
INDUSTRY